Museum of Science, Boston

The museum's Investment Committee oversees endowment deployment, with Philip Rotner serving as a named committee member. Board chair Adam Koppel, a partner at Bain Capital Life Sciences, brings institutional investing expertise to the governance structure. Tim Ritchie, as president, holds ultimate authority over the museum's strategic direction including its long-term capital allocation.

The museum's endowment lists six separate venture capital strategies, operating alongside its public education mission. This is unusual for a museum — cultural endowments typically skew conservative in their allocations. The presence of a Bain Capital partner as board chair likely informs the portfolio's orientation toward direct venture and co-investment opportunities.

Bloomberg Philanthropies funded the William and Charlotte Bloomberg Science Education Center, a major strategic partnership that anchors the museum's educational programming. Michael Bloomberg's organization functions as both a donor and a co-investor in the museum's mission infrastructure, though the full scope of the financial relationship is not publicly disclosed.

The museum is governed by a Board of Trustees chaired by Adam Koppel. An Investment Committee, which includes Philip Rotner, oversees the endowment portfolio. The president, Tim Ritchie, manages day-to-day operations and also serves as Chair of the Association of Science and Technology Centers board, giving the museum influence across the broader science-center industry.

The endowment's six venture capital strategy lines suggest a mix of both fund commitments and direct co-investments, though the institution does not publicly break out its allocation by vehicle type. Because a Bain Capital Life Sciences partner chairs the board, the museum likely has access to co-investment flow that most cultural endowments cannot source independently.

The museum owns the Science Park campus at 1 Science Park in Boston, a commercial parking garage at the same address, and its permanent collection. These real assets sit alongside the financial endowment and represent a significant local real estate position in the Cambridge-adjacent corridor.

The endowment lists six venture capital strategy lines, with a likely emphasis on life sciences given chair Adam Koppel's role at Bain Capital Life Sciences. The museum has not publicly disclosed specific sector exclusions or positive screens, though its board composition suggests comfort with healthcare and biotech venture exposure.